Crosstalk between m6A modification and metabolic reprogramming in colorectal cancer: from the immune microenvironment to clinical applications
The molecular mechanisms through which m6A modification drives the malignant progression of CRC via metabolic regulation are reviewed, the metabolic network involving m6A modification and its role in shaping TME is elucidated, and the clinical potential of targeting m6A modification and/or metabolic pathways is discuss...